Butyrate and Colon Cancer: What Researchers Are Studying

By Brandon, founder of Ozzi · Published October 9, 2026 · Updated October 10, 2026

Why are researchers interested in butyrate and colon cancer?

Researchers are interested in butyrate and colon cancer because the cells lining your colon burn butyrate as their main fuel. People who eat more fiber also get colon cancer less often in large population studies.

Butyrate is a short-chain fatty acid. Your gut bacteria make it when they ferment fiber you can't digest yourself.

The two findings came from opposite ends of science.

The first is basic biology. The cells lining your colon burn butyrate as their main fuel. Researchers showed this in colon cells taken from people during surgery, back in 1980 (Roediger 1980). No other organ runs on a bacterial by-product the way the colon does.

The second comes from population studies. A 2011 review pooled 25 studies that followed large groups of people for years. For every extra 10 grams of fiber a day, colon cancer was about 10% less common. Three daily servings of whole grains went with about 17% less (Aune 2011).

Fiber is exactly what feeds the bacteria that make butyrate. So butyrate became an obvious thing to look at.

Then laboratory work added a detail that researchers found hard to ignore. In lab studies, butyrate fed healthy colon cells while slowing the growth of colon cancer cells (Donohoe 2014). One molecule, two different effects, depending on the cell.

That is the shape of the question researchers are working on now. Our butyrate research hub covers the background if you are new to it.

What is the theory behind butyrate and colon cancer?

The theory is that healthy colon cells burn butyrate for fuel, while cancer cells burn sugar instead, so butyrate builds up inside them. Researchers think that build-up changes which genes are switched on.

A healthy colon cell burns butyrate for fuel. Cancer cells mostly switch to burning sugar instead. That switch is well described in cancer biology.

So when butyrate arrives at a cancer cell, far less of it gets burned. Researchers think it then builds up inside the cell. There it blocks a family of enzymes called HDACs, which help decide which genes are switched on and off.

Blocking those enzymes changes the signal. Genes that tell a cell to stop dividing, or to die on schedule, become easier to switch on.

Step 4 is the part that has not been tested in people yet. Everything in the chain has been observed, but the chain as a whole is still theory.

Butyrate does plenty of other things in the gut, which we cover in our short-chain fatty acids guide and in how to improve gut barrier function.

What have human studies of butyrate and colon cancer found?

No human trial has tested a swallowed butyrate supplement against polyps or colon cancer yet. The closest trials used fiber or a butyrate-loaded starch, and their results were mixed. One found about 10% fewer polyps, a difference too small to be sure of, and a 20-year trial found no difference in colon cancer.

The 2025 polyp trial. Researchers gave 40 grams a day of a starch chemically loaded with butyrate to 72 people with familial adenomatous polyposis, an inherited condition that causes hundreds of colon polyps. Each person took the butyrate starch for 6 months and a plain starch for 6 months, with colonoscopies to count polyps. Polyp counts ran about 10% lower on the butyrate starch. The authors said the difference was too small to be sure and could have been chance (Clarke 2025).

That is the closest anyone has come to testing this idea directly in people. The signal pointed the right way. The trial was not big enough to settle it.

The 20-year starch trial. The longest trial gave 30 grams a day of resistant starch to 918 people with Lynch syndrome, an inherited condition with a high colon cancer risk. Resistant starch is a fiber that colon bacteria turn into butyrate. After up to 20 years, colon cancer counts were nearly the same: 52 on starch and 53 on placebo. Fewer people on starch developed other Lynch-related cancers, mostly in the upper digestive tract, though that was not the question the trial set out to answer (Mathers 2022).

The red meat trial. 23 healthy adults ate 300 grams of red meat a day, which raised a marker of DNA damage in the lining of the rectum. When they added 40 grams a day of the butyrate-loaded starch, that rise did not happen (Le Leu 2015). A marker is an early step on the path, not a polyp and not a cancer, but it is a human result and it points the same way.

We searched PubMed and the US clinical trials registry for a trial of a swallowed butyrate supplement with polyps or cancer as the result. That trial has not been run yet. The other human butyrate trials are below.

The enema trials are useful for a different reason. They show what happens when butyrate is delivered straight to the lower bowel, which is the delivery problem in miniature.

How could the research on butyrate and colon cancer play out?

A bigger, longer trial of butyrate could repeat the 2025 polyp result with a clear difference, or butyrate could turn out to be less useful than hoped, because it is hard to get to the colon.

If it works

Here is what would have to go right.

First, a bigger and longer trial would need to repeat the 2025 polyp result, with a clear difference rather than a small one. Researchers would want it in ordinary adults having routine colonoscopies, not only in people with inherited conditions.

Second, the butyrate would have to arrive where it is needed. That means fiber, resistant starch, or a form built to release in the colon rather than higher up.

Third, the effect would need to be worth having. A 10% difference in polyp counts is interesting to a researcher. An ordinary person would want to know it changes how often polyps come back over years.

If all three landed, the practical upshot would be modest and welcome. More fiber, perhaps a specific colon-release form, alongside the screening schedule you already follow. It would be an addition, not a replacement, and it would be cheap.

If it falls short

Getting butyrate to the colon is hard. A swallowed capsule is absorbed high up in the gut, before the colon. In 30 adults taking 4 grams a day of sodium butyrate capsules for a month, butyrate in stool went up (de Groot 2020). In 23 adults taking butyrate capsules for 4 weeks, butyrate rose in the blood while stool levels stayed flat (Verhaar 2024). So a capsule is not yet a reliable way to raise butyrate in the colon.

The fiber trials in people have been mixed. Two large trials in 2000 found that polyps came back at about the same rate with or without extra fiber. The 20-year starch trial found no difference in colon cancer counts.

Lab findings do not all point one way. In one animal study, butyrate fed the growth of damaged colon cells in animals bred with a faulty DNA repair gene (Belcheva 2014). The effect may depend on the genes involved and how far along the damage is.

None of that makes the idea wrong. It means the next step is a bigger human trial, and that takes time when the result you are measuring takes years to appear.

What can you do for your colon today?

Colon cancer screening comes first, and so does your doctor. The US Preventive Services Task Force recommends colon cancer screening for all adults aged 45 to 75 (USPSTF 2021). Screening finds polyps and removes them before they can become a problem. That advice is for people at average risk with no symptoms. If you have a family history, a past polyp, inflammatory bowel disease or any symptom that worries you, your own doctor sets the plan, and that conversation is worth more than anything on this page.

Butyrate supplements are not a treatment for cancer. Nothing in this research is a reason to put off a colonoscopy.

Eat the fiber. Beans, lentils, oats, whole grains, vegetables and fruit all feed the bacteria that make butyrate in your colon. This is the one lever here with decades of human data behind it, and it is the cheapest. Our guide on how to increase butyrate naturally lists the foods that do most of the work.

Build up slowly if your diet is low in fiber now. Going from very little to a great deal in one week is uncomfortable and most people quit.

We sell a butyrate supplement, which is why we read this research closely. On this particular question, the food comes first and the trial that would answer it has not been run.

If you want the wider picture on what butyrate does, our pages on butyrate and inflammation, butyrate and liver health and gut health and GLP-1 cover the other areas researchers are working on.

Frequently asked questions

This article is for educational purposes and isn't medical advice. It describes published research on butyrate, not the effects of any Ozzi product. Ozzi products are dietary supplements and are not intended to diagnose, treat, cure, or prevent any disease. Talk to your healthcare provider before starting any supplement, especially if you have a medical condition or take medication.

References

1. Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut. 1980. PubMed 7429343
2. Aune D, et al. Dietary fibre, whole grains, and risk of colorectal cancer. BMJ. 2011. PubMed 22074852
3. Donohoe DR, et al. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov. 2014. PubMed 25266735
4. Belcheva A, et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell. 2014. PubMed 25036629
5. Clarke JM, et al. The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis. Cancer Prev Res. 2025. PubMed 40947861
6. Mathers JC, et al. Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2 Trial. Cancer Prev Res. 2022. PubMed 35878732
7. Le Leu RK, et al. Butyrylated starch intake can prevent red meat-induced O6-methyl-2-deoxyguanosine adducts in human rectal tissue. Br J Nutr. 2015. PubMed 26084032
8. Schatzkin A, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med. 2000. PubMed 10770979
9. Alberts DS, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med. 2000. PubMed 10770980
10. Vernia P, et al. Topical butyrate for acute radiation proctitis. Lancet. 2000. PubMed 11072942
11. Maggio A, et al. Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy. Int J Radiat Oncol Biol Phys. 2014. PubMed 24803033
12. de Groot PF, et al. Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes. Diabetologia. 2020. PubMed 31915895
13. Verhaar BJH, et al. Effects of Oral Butyrate on Blood Pressure in Patients With Hypertension: A Randomized, Placebo-Controlled Trial. Hypertension. 2024. PubMed 39034917